Cardiology, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon.
Cardiologie, Centre Hospitalier de Haguenau, Haguenau, Alsace-Champagne-Ardenne-Lorraine, France.
Open Heart. 2022 Jun;9(1). doi: 10.1136/openhrt-2022-002030.
Severe tricuspid regurgitation (TR) is an undertreated common pathology associated with significant morbidity and mortality. Classically, surgical repair or valve replacement were the only therapeutic options and are associated with up to 10% postprocedural mortality. Transcatheter tricuspid valve interventions are a novel and effective therapeutic option for the treatment of significant TR. Several devices have been developed with different mechanisms of action. They are classified as annuloplasty devices, replacement devices, caval valve implantation and coaptation devices. In this review, we provide a step-by-step description of the procedural steps and techniques of every device along with video support.
严重三尖瓣反流（TR）是一种治疗不足的常见病理学，与显著的发病率和死亡率相关。传统上，手术修复或瓣膜置换是唯一的治疗选择，其术后死亡率高达 10%。经导管三尖瓣介入治疗是一种新颖而有效的治疗严重 TR 的方法。已经开发了几种具有不同作用机制的设备。它们被分类为瓣环成形术设备、置换设备、腔静脉瓣植入和瓣叶对合装置。在这篇综述中，我们提供了每个设备的程序步骤和技术的分步描述，并附有视频支持。
